NeoGenomics Laboratories
This remote position involves interpreting molecular oncology results using techniques like Next-Generation Sequencing (NGS) and Sanger sequencing to provide accurate diagnoses and prognoses for genetic disorders. The role requires performing quality control procedures, participating in daily operations, and serving as a clinical consultant to resolve case issues. The position offers a competitive compensation package with equity participation and opportunities for professional growth within a multidisciplinary environment.
Headquarters
Fort Myers, Florida, United States
Company Size
1001-5000 employees
Founded
2002
NeoGenomics Laboratories is a specialty clinical laboratory focused on precision oncology testing that helps healthcare providers optimize cancer diagnosis, treatment, and monitoring. It offers molecular and anatomic pathology services, next‑generation sequencing panels and proprietary assays such as RaDaR ST for measurable residual disease and the PanTracer portfolio for comprehensive genomic insights. The company also supports biopharma partners with regulatory and clinical trial services, provides oncology data solutions, and offers provider tools (NeoLINK, EHR integrations, test search) and client support to streamline clinical and research workflows. Known for an extensive test menu and clinician-focused resources, NeoGenomics aims to deliver actionable results that improve patient care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for NeoGenomics Laboratories.